The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage

Young people who experience multiple disadvantage have been identified as some of the most marginalised and under-serviced people in the alcohol and other drug (AOD) system. In this paper, we draw on a range of research evidence to argue that one of the challenges in responding appropriately to the...

Full description

Bibliographic Details
Published in:International Journal of Drug Policy
Main Authors: Bryant, J., Caluzzi, G., Bruun, A., Sundbery, J., Ferry, M., Gray, R. M., Skattebol, J., Neale, J., MacLean, S.
Format: Article in Journal/Newspaper
Language:English
Published: 2022
Subjects:
Online Access:https://kclpure.kcl.ac.uk/portal/en/publications/the-problem-of-overmedicalisation(b6496d34-06b5-4919-801b-0d010bcd75be).html
https://doi.org/10.1016/j.drugpo.2022.103631
http://www.scopus.com/inward/record.url?scp=85125837015&partnerID=8YFLogxK
id ftkingscollondon:oai:pure.atira.dk:publications/b6496d34-06b5-4919-801b-0d010bcd75be
record_format openpolar
spelling ftkingscollondon:oai:pure.atira.dk:publications/b6496d34-06b5-4919-801b-0d010bcd75be 2023-05-15T16:16:49+02:00 The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage Bryant, J. Caluzzi, G. Bruun, A. Sundbery, J. Ferry, M. Gray, R. M. Skattebol, J. Neale, J. MacLean, S. 2022-05 https://kclpure.kcl.ac.uk/portal/en/publications/the-problem-of-overmedicalisation(b6496d34-06b5-4919-801b-0d010bcd75be).html https://doi.org/10.1016/j.drugpo.2022.103631 http://www.scopus.com/inward/record.url?scp=85125837015&partnerID=8YFLogxK eng eng info:eu-repo/semantics/restrictedAccess Bryant , J , Caluzzi , G , Bruun , A , Sundbery , J , Ferry , M , Gray , R M , Skattebol , J , Neale , J & MacLean , S 2022 , ' The problem of over-medicalisation : How AOD disease models perpetuate inequity for young people with multiple disadvantage ' , International Journal of Drug Policy , vol. 103 , 103631 . https://doi.org/10.1016/j.drugpo.2022.103631 Alcohol and drug treatment Medicalisation Multiple disadvantage Young people article 2022 ftkingscollondon https://doi.org/10.1016/j.drugpo.2022.103631 2022-10-14T10:53:21Z Young people who experience multiple disadvantage have been identified as some of the most marginalised and under-serviced people in the alcohol and other drug (AOD) system. In this paper, we draw on a range of research evidence to argue that one of the challenges in responding appropriately to the needs of these young people are models of care which seek to ameliorate ‘illness’ rather than promote wellness. While disease approaches have some important benefits, overly-medicalised AOD treatment responses also have negative impacts. We argue that disease models rest on understandings of substance use as an individual enterprise and thereby pay insufficient attention to the material disadvantage that shape young people's substance use, creating feelings of shame, failure and a reluctance to return to care if they continue to use. Additionally we draw on literature that shows how disease models construe young people's substance use as compulsive, perpetuating deficit views of them as irrational and failing to account for the specific meanings that young people themselves give to their substance use. By focusing on clinical solutions rather than material and relational ones, medicalised treatment responses perpetuate inequity: they benefit young people whose resources and normative values align with the treatments offered by disease models, but are much less helpful to those who are under-resourced,. We suggest that alternative approaches can be found in First Nations models of care and youth programs that attend to social, cultural, and material wellbeing, making living well the focus of treatment rather than illness amelioration. Article in Journal/Newspaper First Nations King's College, London: Research Portal International Journal of Drug Policy 103 103631
institution Open Polar
collection King's College, London: Research Portal
op_collection_id ftkingscollondon
language English
topic Alcohol and drug treatment
Medicalisation
Multiple disadvantage
Young people
spellingShingle Alcohol and drug treatment
Medicalisation
Multiple disadvantage
Young people
Bryant, J.
Caluzzi, G.
Bruun, A.
Sundbery, J.
Ferry, M.
Gray, R. M.
Skattebol, J.
Neale, J.
MacLean, S.
The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
topic_facet Alcohol and drug treatment
Medicalisation
Multiple disadvantage
Young people
description Young people who experience multiple disadvantage have been identified as some of the most marginalised and under-serviced people in the alcohol and other drug (AOD) system. In this paper, we draw on a range of research evidence to argue that one of the challenges in responding appropriately to the needs of these young people are models of care which seek to ameliorate ‘illness’ rather than promote wellness. While disease approaches have some important benefits, overly-medicalised AOD treatment responses also have negative impacts. We argue that disease models rest on understandings of substance use as an individual enterprise and thereby pay insufficient attention to the material disadvantage that shape young people's substance use, creating feelings of shame, failure and a reluctance to return to care if they continue to use. Additionally we draw on literature that shows how disease models construe young people's substance use as compulsive, perpetuating deficit views of them as irrational and failing to account for the specific meanings that young people themselves give to their substance use. By focusing on clinical solutions rather than material and relational ones, medicalised treatment responses perpetuate inequity: they benefit young people whose resources and normative values align with the treatments offered by disease models, but are much less helpful to those who are under-resourced,. We suggest that alternative approaches can be found in First Nations models of care and youth programs that attend to social, cultural, and material wellbeing, making living well the focus of treatment rather than illness amelioration.
format Article in Journal/Newspaper
author Bryant, J.
Caluzzi, G.
Bruun, A.
Sundbery, J.
Ferry, M.
Gray, R. M.
Skattebol, J.
Neale, J.
MacLean, S.
author_facet Bryant, J.
Caluzzi, G.
Bruun, A.
Sundbery, J.
Ferry, M.
Gray, R. M.
Skattebol, J.
Neale, J.
MacLean, S.
author_sort Bryant, J.
title The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
title_short The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
title_full The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
title_fullStr The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
title_full_unstemmed The problem of over-medicalisation:How AOD disease models perpetuate inequity for young people with multiple disadvantage
title_sort problem of over-medicalisation:how aod disease models perpetuate inequity for young people with multiple disadvantage
publishDate 2022
url https://kclpure.kcl.ac.uk/portal/en/publications/the-problem-of-overmedicalisation(b6496d34-06b5-4919-801b-0d010bcd75be).html
https://doi.org/10.1016/j.drugpo.2022.103631
http://www.scopus.com/inward/record.url?scp=85125837015&partnerID=8YFLogxK
genre First Nations
genre_facet First Nations
op_source Bryant , J , Caluzzi , G , Bruun , A , Sundbery , J , Ferry , M , Gray , R M , Skattebol , J , Neale , J & MacLean , S 2022 , ' The problem of over-medicalisation : How AOD disease models perpetuate inequity for young people with multiple disadvantage ' , International Journal of Drug Policy , vol. 103 , 103631 . https://doi.org/10.1016/j.drugpo.2022.103631
op_rights info:eu-repo/semantics/restrictedAccess
op_doi https://doi.org/10.1016/j.drugpo.2022.103631
container_title International Journal of Drug Policy
container_volume 103
container_start_page 103631
_version_ 1766002676657553408